Intuitive Surgical, Inc. $ISRG Stake Decreased by Achmea Investment Management B.V.

Achmea Investment Management B.V. lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,693 shares of the medical equipment provider’s stock after selling 877 shares during the period. Achmea Investment Management B.V.’s holdings in Intuitive Surgical were worth $18,852,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of ISRG. Norway Savings Bank grew its holdings in shares of Intuitive Surgical by 53.4% in the 2nd quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after buying an additional 910 shares during the period. IronOak Wealth LLC. bought a new position in Intuitive Surgical in the second quarter valued at $1,099,000. Trust Co. of Oklahoma acquired a new position in Intuitive Surgical during the second quarter valued at approximately $363,000. Amalgamated Bank increased its holdings in Intuitive Surgical by 2.2% during the second quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock worth $44,311,000 after buying an additional 1,772 shares during the last quarter. Finally, Neville Rodie & Shaw Inc. grew its holdings in Intuitive Surgical by 11.9% during the second quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock worth $5,666,000 after purchasing an additional 1,110 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, Director Craig H. Barratt sold 2,193 shares of the company’s stock in a transaction on Friday, October 24th. The shares were sold at an average price of $548.01, for a total value of $1,201,785.93. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO David J. Rosa sold 24,500 shares of the company’s stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $547.55, for a total value of $13,414,975.00. Following the completion of the transaction, the chief executive officer owned 234,256 shares of the company’s stock, valued at $128,266,872.80. The trade was a 9.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 96,011 shares of company stock valued at $50,309,042. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Up 1.8%

Intuitive Surgical stock opened at $548.55 on Thursday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The company has a market cap of $196.64 billion, a P/E ratio of 72.56, a P/E/G ratio of 4.94 and a beta of 1.61. The business has a 50-day simple moving average of $468.68 and a two-hundred day simple moving average of $499.90.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same period in the previous year, the business posted $1.84 earnings per share. The firm’s quarterly revenue was up 22.9% compared to the same quarter last year. Research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have weighed in on ISRG shares. Erste Group Bank reissued a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Jefferies Financial Group boosted their target price on shares of Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a report on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Hsbc Global Res upgraded shares of Intuitive Surgical to a “strong-buy” rating in a research note on Thursday, October 23rd. Finally, The Goldman Sachs Group increased their target price on shares of Intuitive Surgical from $567.00 to $621.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $608.92.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.